{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:19:34Z","timestamp":1787653174537,"version":"build-2736575974"},"reference-count":40,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"ICU Medical SA Pty Ltd. 1 Bompas Rd, Dunkeld, Johannesburg, RSA"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Antineoplastic drugs (ADs) are hazardous substances commonly used in medical oncology, posing health risks to pharmacy personnel through occupational exposure. Despite safety guidelines, contamination of surfaces in oncology pharmacies remains prevalent. In this study, we assessed surface contamination and biological uptake of ADs in selected South African oncology pharmacies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Six pharmacies (three from each of two medical oncology service providers, SP1 and SP2) participated. Surface wipe samples were collected from three areas in each pharmacy (containment-primary engineering control (C-PEC), floor, adjacent surface) before and after decontamination procedures. Nine ADs were quantified, using high-pressure liquid chromatography tandem mass spectrometry (HPLC-MS\/MS). 24-h urine samples were collected from six pharmacy personnel. The DeRmal Exposure Assessment Method (DREAM) was used to estimate exposure risks. The results were compared with those from an observational study that assessed compliance with safety protocols in the same six pharmacies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Surface contamination was higher in SP1 than in SP2 pharmacies, with 5-fluorouracil (5-FU) being the most frequently detected AD. Post-decontamination samples showed a 17.4% reduction in 5-FU contamination, although SP1 pharmacies still had higher post-decontamination concentrations than SP2 pharmacies, especially on floors. Cyclophosphamide and ifosphamide were detected in the urine of two participants from SP1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We demonstrated higher contamination and occupational exposure risks in SP1 than in SP2 pharmacies, indicating a need for strict decontamination protocols and better use of personal protective equipment in the SP1 pharmacies. The SP2 pharmacies may serve as a model for oncology pharmacy safety in South Africa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552251321150","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T04:14:05Z","timestamp":1740370445000},"page":"1066-1075","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing antineoplastic drug contamination in South African oncology pharmacies: Workplace and biological monitoring"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8065-7562","authenticated-orcid":false,"given":"Ruan","family":"Botha","sequence":"first","affiliation":[{"name":"University of the Witwatersrand, Johannesburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7851-4445","authenticated-orcid":false,"given":"Gill","family":"Nelson","sequence":"additional","affiliation":[{"name":"University of the Witwatersrand, Johannesburg"},{"name":"Barrow Neurological Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8580-0044","authenticated-orcid":false,"given":"Paul","family":"Sessink","sequence":"additional","affiliation":[{"name":"Exposure Control Sweden, Bohus-Bj\u00f6rk\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1750-3715","authenticated-orcid":false,"given":"Derk","family":"Brouwer","sequence":"additional","affiliation":[{"name":"University of the Witwatersrand, Johannesburg"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155210381931"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/annweh\/wxx065"},{"key":"e_1_3_2_4_2","first-page":"33","article-title":"Occupational exposure of nursing personnel to antineoplastic agents","volume":"12","author":"Cloak MM","year":"1985","unstructured":"Cloak MM, Connor TH, Stevens KR, et al. Occupational exposure of nursing personnel to antineoplastic agents. Oncol Nurs Forum 1985; 12: 33\u201339.","journal-title":"Oncol Nurs Forum"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/56.14.1427"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/10781552231167329"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155217726160"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91939-1"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(91)90012-U"},{"key":"e_1_3_2_10_2","first-page":"271","article-title":"Leukemia from dermal exposure to cyclophosphamide among nurses in The Netherlands: quantitative assessment of the risk","volume":"58","author":"Fransman W","year":"2014","unstructured":"Fransman W, Kager H, Meijster T, et al. Leukemia from dermal exposure to cyclophosphamide among nurses in The Netherlands: quantitative assessment of the risk. Ann Occup Hyg 2014; 58: 271\u2013282.","journal-title":"Ann Occup Hyg"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Herndon CM Nee D Atayee RS et al. ASHP guidelines on the pharmacist's role in palliative and hospice care. Am J Health Syst Pharm 2016; 73: 1351\u20131367. DOI: https:\/\/doi.org\/10.2146\/ajhp160244","DOI":"10.2146\/ajhp160244"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/10781552211070933"},{"key":"e_1_3_2_13_2","unstructured":"European Society of Oncology Pharmacy. Quality Standard for the Oncology Pharmacy Service (QuaPos 6). 2018. https:\/\/esop.li\/wp-content\/uploads\/2020\/01\/QuapoS_english-6.pdf"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1188\/17.CJON.179-187"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.0851501"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4878(00)00050-8"},{"key":"e_1_3_2_17_2","first-page":"237","article-title":"Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study","volume":"48","author":"Fransman W","year":"2004","unstructured":"Fransman W, Vermeulen R, Kromhout H. Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study. Ann Occup Hyg 2004; 48: 237\u2013244.","journal-title":"Ann Occup Hyg"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-004-0595-1"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19063737"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijpp.12590"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155216643860"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155216676632"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v72i1.2870"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0281"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155219859424"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155221995539"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cptl.2022.05.001"},{"key":"e_1_3_2_28_2","unstructured":"Van der Merwe C. The daily struggles of an oncology pharmacist. Buddies for life 2016."},{"key":"e_1_3_2_29_2","article-title":"A pilot study of South African oncology pharmacy facilities: comparison with best practice guidelines","volume":"7","author":"Botha R","year":"2024","unstructured":"Botha R, Nelson G, Brouwer D. A pilot study of South African oncology pharmacy facilities: comparison with best practice guidelines. Eur J Oncol Pharm 2024; 7: e00056.","journal-title":"Eur J Oncol Pharm"},{"key":"e_1_3_2_30_2","first-page":"107815522312054","article-title":"Longitudinal evaluation of environmental contamination with hazardous drugs by surface wipe sampling","author":"Sessink PJ","year":"2023","unstructured":"Sessink PJ, Tans B, Spriet I, et al. Longitudinal evaluation of environmental contamination with hazardous drugs by surface wipe sampling. J Oncol Pharm Pract 2023: 10781552231205481. DOI: https:\/\/doi.org\/10.1177\/10781552231205481","journal-title":"J Oncol Pharm Pract"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/annweh\/wxad026"},{"key":"e_1_3_2_32_2","first-page":"71","article-title":"DREAM: a method for semi-quantitative dermal exposure assessment","volume":"47","author":"Van-Wendel-de-Joode B","year":"2003","unstructured":"Van-Wendel-de-Joode B, Brouwer DH, Vermeulen R, et al. DREAM: a method for semi-quantitative dermal exposure assessment. Ann Occup Hyg 2003; 47: 71\u201387.","journal-title":"Ann Occup Hyg"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/15459624.2016.1165912"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155217704990"},{"key":"e_1_3_2_35_2","first-page":"00","article-title":"Protecting the health care workforce from cytotoxic drugs contamination in the hospital wards: the results of the pan-European MASHA-2 project","volume":"6","author":"Korczowska E","year":"2023","unstructured":"Korczowska E, Crul M, Wolc A, et al. Protecting the health care workforce from cytotoxic drugs contamination in the hospital wards: the results of the pan-European MASHA-2 project. Eur J Oncol Pharm 2023; 6: 00.","journal-title":"Eur J Oncol Pharm"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19148601"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155221992103"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155219831427"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/15459624.2020.1854458"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155213497070"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20064952"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552251321150","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552251321150","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552251321150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:31:48Z","timestamp":1787650308000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552251321150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1177\/10781552251321150"],"URL":"https:\/\/doi.org\/10.1177\/10781552251321150","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]}}}